U.S. Markets closed

DexCom, Inc. (DXCM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
405.10-3.99 (-0.98%)
At close: 4:00PM EDT
405.10 0.00 (0.00%)
After hours: 04:20PM EDT

DexCom, Inc.

6340 Sequence Drive
San Diego, CA 92121
United States
858 200 0200

IndustryDiagnostics & Research
Full Time Employees5,500

Key Executives

NameTitlePayExercisedYear Born
Mr. Kevin Ronald SayerExec. Chairman, CEO & Pres2.63MN/A1958
Mr. Quentin S. BlackfordChief Operating Officer1.48MN/A1979
Mr. Jacob Steven LeachExec. VP & CTO1M3.28M1978
Mr. Jereme M. SylvainExec. VP, CFO & Chief Accounting OfficerN/AN/A1980
Mr. Sean ChristensenDirector of Corp. Affairs & Head of Investor RelationsN/AN/AN/A
Mr. Patrick Michael MurphyExec. VP & Chief Legal OfficerN/AN/A1979
Mr. Chad M. PattersonExec. VP of Global MarketingN/AN/A1982
Ms. Sadie M. SternExec. VP & Chief HR OfficerN/AN/A1975
Mr. Andrew K. BaloExec. VP of Regulatory Strategy, Clinical Affairs & Strategic Partnership Devel.N/AN/A1948
Mr. Steven R. PacelliExec. VP & MD of Dexcom VenturesN/AN/A1972
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Corporate Governance

DexCom, Inc.’s ISS Governance QualityScore as of April 30, 2021 is 7. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 8; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.